title: Assessment of pharmacokinetic changes of meropenem during therapy in septic critically ill patients.
abstract: BACKGROUND
  Meropenem is a carbapenem antibiotic commonly used in critically ill patients to treat severe infections. The available pharmacokinetic (PK) data has been mostly obtained from healthy volunteers as well as from clinical studies addressing selected populations, often excluding the elderly and also patients with renal failure. Our aim was to study PK of meropenem in a broader population of septic critically ill patients.
  
  
  METHODS
  We characterized the PK of meropenem in 15 critically ill patients during the first 36 hrs of therapy. Aditionally, whenever possible, we collected a second set of late plasma samples after 5 days of therapy to evaluate PK intra-patient variability and its correlation with clinical course.Patients received meropenem (1 g every 8 hrs IV). Drug plasma profiles were determined by high-performance liquid chromatography. The PK of meropenem was characterized and compared with clinical parameters.
  
  
  RESULTS
  Fifteen septic critically ill patients (8 male, median age 73 yrs) were included. The geometric mean of the volume of distribution at the steady state (Vss)/weight was 0.20 (0.15-0.27) L/kg. No correlation of Vss/weight with severity or comorbidity scores was found. However the Sequential Organ Failure Assessment score correlated with the Vss/weight of the peripheral compartment (r2 = 0.55, p = 0.021). The median meropenem clearance (Cl) was 73.3 (45-120) mL/min correlated with the creatinine (Cr) Cl (r2 = 0.35, p = 0.033).After 5 days (N = 7) although Vss remained stable, a decrease in the proportion of the peripheral compartment (Vss2) was found, from 61.3 (42.5-88.5)% to 51.7 (36.6-73.1)%. No drug accumulation was noted.
  
  
  CONCLUSIONS
  In this cohort of septic, unselected, critically ill patients, large meropenem PK heterogeneity was noted, although neither underdosing nor accumulation was found. However, Cr Cl correlated to meropenem Cl and the Vss2 decreased with patient's improvement.
authors.affiliation: Polyvalent Intensive Care Unit, São Francisco Xavier Hospital, CHLO, Lisbon, Portugal, Estrada do Forte do Alto do Duque, Lisboa 1449-005, Portugal. joaogpster@gmail.com.
authors.forename: João
authors.initials: J
authors.lastname: Goncalves-Pereira
authors.forename: Nuno Elvas
authors.initials: NE
authors.lastname: Silva
authors.forename: André
authors.initials: A
authors.lastname: Mateus
authors.forename: Catarina
authors.initials: C
authors.lastname: Pinho
authors.forename: Pedro
authors.initials: P
authors.lastname: Povoa
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016638:Critical Illness; D005260:Female; D006801:Humans; D008297:Male; D000077731:Meropenem; D008875:Middle Aged; D018805:Sepsis / Q000188:drug therapy / Q000378:metabolism*; D013845:Thienamycins / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D013845:Thienamycins; D000077731:Meropenem
references.citation: Clin Lab Med. 2004 Jun;24(2):477-502
references.pmid: 15177850
references.citation: Clin Pharmacokinet. 2006;45(8):755-73
references.pmid: 16884316
references.citation: Crit Care. 2010;14(4):R126
references.pmid: 20594297
references.citation: Crit Care Med. 2009 Jun;37(6):2071-8
references.pmid: 19384201
references.citation: J Antimicrob Chemother. 2009 Jul;64(1):142-50
references.pmid: 19398460
references.citation: J Crit Care. 2013 Aug;28(4):341-6
references.pmid: 23337485
references.citation: Anaesth Intensive Care. 2008 Sep;36(5):674-80
references.pmid: 18853585
references.citation: Drugs. 2007;67(7):1027-52
references.pmid: 17488146
references.citation: Crit Care. 2011 Jun 08;15(3):R139
references.pmid: 21651804
references.citation: Crit Care Clin. 2009 Oct;25(4):677-702, vii
references.pmid: 19892247
references.citation: Int J Antimicrob Agents. 2008 Apr;31(4):345-51
references.pmid: 18313273
references.citation: Crit Care. 2011;15(5):R206
references.pmid: 21914174
references.citation: Int J Antimicrob Agents. 2013 Feb;41(2):162-6
references.pmid: 23153962
references.citation: Crit Care. 2012 Jun 28;16(3):R113
references.pmid: 22742765
references.citation: J Antimicrob Chemother. 1995 Jul;36(1):165-72
references.pmid: 8537263
references.citation: J Chronic Dis. 1987;40(5):373-83
references.pmid: 3558716
references.citation: Ther Drug Monit. 2013 Feb;35(1):63-70
references.pmid: 23318279
references.citation: Crit Care Med. 2014 Mar;42(3):520-7
references.pmid: 24201175
references.citation: Crit Care. 2009;13(3):214
references.pmid: 19519961
references.citation: PLoS One. 2012;7(11):e49845
references.pmid: 23185458
references.citation: Antimicrob Agents Chemother. 2005 Apr;49(4):1337-9
references.pmid: 15793108
references.citation: Int J Antimicrob Agents. 2002 Feb;19(2):105-10
references.pmid: 11850162
references.citation: Int J Antimicrob Agents. 2013 Nov;42(5):422-8
references.pmid: 23993066
references.citation: Clin Infect Dis. 2013 Jan;56(2):236-44
references.pmid: 23074313
references.citation: Intensive Care Med. 1990;16(5):303-6
references.pmid: 2212254
references.citation: Crit Care. 2008;12 Suppl 4:S2
references.pmid: 18495059
references.citation: J Antimicrob Chemother. 2000 Jul;46(1):150-1
references.pmid: 10882710
references.citation: Antimicrob Agents Chemother. 2007 Sep;51(9):3304-10
references.pmid: 17620371
references.citation: Crit Care. 2013 Apr 16;17(2):130
references.pmid: 23672959
references.citation: Crit Care. 2013 May 03;17(3):R84
references.pmid: 23642005
references.citation: Intensive Care Med. 1996 Jul;22(7):707-10
references.pmid: 8844239
references.citation: Clin Biochem. 2010 Apr;43(6):589-98
references.pmid: 20036226
references.citation: JAMA. 1993 Dec 22-29;270(24):2957-63
references.pmid: 8254858
references.citation: Ann Intensive Care. 2012 Jul 28;2(1):35
references.pmid: 22839761
references.citation: Anesth Analg. 2003 Oct;97(4):1149-1154
references.pmid: 14500173
references.citation: Lancet Infect Dis. 2005 Sep;5(9):581-9
references.pmid: 16122681